Modern management of tuberculosis.
D000293:Adolescent; D000328:Adult; D010131:Aminosalicylic Acid / Q000009:adverse effects; D002648:Child; D003523:Cycloserine / Q000009:adverse effects; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000009:adverse effects / Q000627:therapeutic use; D005000:Ethionamide / Q000009:adverse effects; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D011718:Pyrazinamide / Q000009:adverse effects; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use; D013307:Streptomycin / Q000009:adverse effects / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control
D011718:Pyrazinamide; D010131:Aminosalicylic Acid; D004977:Ethambutol; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin